|This article needs additional citations for verification. (May 2010)|
|Classification and external resources|
Non-contrast computed tomography of head showing a large mass without any intracranial extension. The diagnosis was postauricular congenital alveolar rhabdomyosarcoma.
A rhabdomyosarcoma, commonly referred to as RMS, is a type of cancer, specifically a sarcoma (cancer of connective tissues), in which the cancer cells are thought to arise from skeletal muscle progenitors. It can also be found attached to muscle tissue, wrapped around intestines, or in any anatomic location. Most occur in areas naturally lacking in skeletal muscle, such as the head, neck, and genitourinary tract.
Its two most common forms are embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma. In the former, which is more common in younger children, the cancer cells resemble those of a typical 6-to-8-week embryo. In the latter, which is more common in older children and teenagers, they resemble those of a typical 10-to-12-week embryo.
Rhabdomyosarcoma is a relatively rare form of cancer. When RMS does occur, it is most commonly seen in children aged one to five years old. Less commonly, it can also present in teens aged 15 to 19, and can even develop in adulthood, though this is even more rare.
The diagnosis of rhabdomyosarcoma is made by a pathologist; he or she will examine a biopsy of the tumor under the microscope and arrive at the diagnosis of rhabdomyosarcoma based on the morphology (appearance) of the tumor cells and the results of immunohistochemical stains.
Diagnosis of rhabdomyosarcoma depends on recognition of differentiation toward skeletal muscle cells. The proteins myoD1 and myogenin are transcription factor proteins normally found in developing skeletal muscle cells which disappears after the muscle matures and becomes innervated by a nerve. Thus, myoD1 and myogenin are not usually found in normal skeletal muscle and serve as a useful immunohistochemical marker of rhabdomyosarcoma.
Early manifestation can be misdiagnosed as a pseudotumor that is non responsive to steroid treatment.
MRI is the imaging modality of choice for the assessement of the primary adult rhabdomyosarcoma involving most body regions with additional value of diffusion weighted imaging and whole body MRI for staging.
Several different histological subtypes of rhabdomyosarcoma exist, each of which has different clinical and pathological characteristics. Prognosis and clinical behavior of the tumor is also partially dependent on histologic subtype. Multiple classification systems have been proposed for subclassifying these tumors. The most recent classification system, the "International Classification of Rhabdomyosarcoma", was created by the Intergroup Rhabdomyosarcoma Study. This system attempts to combined elements of the previous systems and correlate these with prognosis based on tumor type.
International Classification of Rhabdomyosarcoma
|Botryoid Rhabdomyosarcoma||Superior Prognosis|
|Spindle cell rhabdomyosarcoma||Superior Prognosis|
|Embryonal rhabdomyosarcoma||Intermediate Prognosis|
|Alveolar rhabdomyosarcoma||Poor Prognosis|
|Undifferentiated Sarcoma||Poor Prognosis|
Several additional subtypes of rhabdomyosarcoma exist that do not fit into the International Classification scheme. Pleomorphic rhabdomyosarcoma usually occurs in adults rather than children, and, thus, is not included in this system. Sclerosing rhabdomyosarcoma is a rare rhabdomyosarcoma subtype recently characterized by Folpe, et al.; it is not included in this system.
Although botryoid and spindle cell rhabdomyosarcoma are classically considered as subtypes of embryonal rhabdomyosarcoma, they have more favorable clinical behavior and prognosis than classic embryonal rhabdomyosarcoma.
If there is no evidence of metastasis, surgery combined with chemotherapy and radiation offers the best prognosis. Patients whose tumors have not metastasized usually have a good chance for long-term survival, depending on the subtype of the tumor.
St Jude's Children's Research Hospital reports that more than 70% of children diagnosed with localized rhabdomyosarcoma have long-term survival.
Tungsten Alloy and RMS
A study has shown a link between RMS and Tungsten alloy embedded in muscle (e.g. bullet or missile fragments).  However, the tungsten alloy contained 6% Nickel, which is a known carcinogen. A synergistic effect of alloying tungsten with Ni is suggested (i.e. increasing the toxicity relative to either of the pure metals).
- Newton WA, Gehan EA, Webber BL, et al. (September 1995). "Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification—an Intergroup Rhabdomyosarcoma Study". Cancer 76 (6): 1073–85. doi:10.1002/1097-0142(19950915)76:6<1073::AID-CNCR2820760624>3.0.CO;2-L. PMID 8625211.
- Kalinich, John F.; Emond, Christy A.; Dalton, Thomas K.; Mog, Steven R.; Coleman, Gary D.; Kordell, Jessica E.; Miller, Alexandra C.; McClain, David E. (14 February 2005). "Embedded Weapons-Grade Tungsten Alloy Shrapnel Rapidly Induces Metastatic High-Grade Rhabdomyosarcomas in F344 Rats". Environmental Health Perspectives 113 (6): 729–734. doi:10.1289/ehp.7791. PMC 1257598. PMID 15929896.
3. Saboo SS, Krajewski KM, Zukotynski K, Howard S, Jagannathan JP, Hornick JL, Ramaiya N. Imaging features of primary and secondary adult rhabdomyosarcoma. AJR Am J Roentgenol. 2012 Dec;199(6):W694-703. doi: 10.2214/AJR.11.8213. Review. PubMed PMID: 23169742.
-  A booklet for parents telling them about Rhabdomyosarcoma and what to do if you have a child with this type of cancer
- HP:1956 Rhabdomyosarcomas at humpath.com (Digital slides)
- Rhabdomyosarcoma by Leonard Wexler, MD in the Sarcoma Learning Center
- Ped-Onc Resource Center
- Information about Rhabdomyosarcoma from St. Jude Children's Research Hospital
- "What is Rhabdomyosarcoma?". Cancer.org.